AU4580599A - Stable no-delivering compounds - Google Patents

Stable no-delivering compounds

Info

Publication number
AU4580599A
AU4580599A AU45805/99A AU4580599A AU4580599A AU 4580599 A AU4580599 A AU 4580599A AU 45805/99 A AU45805/99 A AU 45805/99A AU 4580599 A AU4580599 A AU 4580599A AU 4580599 A AU4580599 A AU 4580599A
Authority
AU
Australia
Prior art keywords
stable
delivering compounds
delivering
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU45805/99A
Other languages
English (en)
Inventor
Jonathan S Stamler
Eric J. Toone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Duke University Medical Center
Original Assignee
Duke University Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duke University Medical Center filed Critical Duke University Medical Center
Publication of AU4580599A publication Critical patent/AU4580599A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/23—Solid materials, e.g. granules, powders, blocks or tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/20—Gaseous substances, e.g. vapours
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/114—Nitric oxide, i.e. NO
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Prostheses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
AU45805/99A 1998-06-23 1999-06-21 Stable no-delivering compounds Abandoned AU4580599A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/103,227 US6207855B1 (en) 1998-06-23 1998-06-23 Stable no-delivering compounds
US09103227 1998-06-23
PCT/US1999/013963 WO1999067210A1 (en) 1998-06-23 1999-06-21 Stable no-delivering compounds

Publications (1)

Publication Number Publication Date
AU4580599A true AU4580599A (en) 2000-01-10

Family

ID=22294054

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45805/99A Abandoned AU4580599A (en) 1998-06-23 1999-06-21 Stable no-delivering compounds

Country Status (7)

Country Link
US (6) US6207855B1 (https=)
EP (1) EP1089969B1 (https=)
JP (1) JP2002518473A (https=)
AU (1) AU4580599A (https=)
CA (1) CA2335989A1 (https=)
DE (1) DE69942338D1 (https=)
WO (1) WO1999067210A1 (https=)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207855B1 (en) 1998-06-23 2001-03-27 Duke University Medical Center Stable no-delivering compounds
TWI243672B (en) * 1999-06-01 2005-11-21 Astrazeneca Ab New use of compounds as antibacterial agents
EP1267837A4 (en) * 2000-03-20 2006-05-03 Novovascular Inc MATRICES COMPRISING NITRIC OXIDE DONORS AND REDUCING AGENTS AND THEIR USE
WO2003026717A1 (en) * 2001-09-26 2003-04-03 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Nitric oxide-releasing coated medical devices and method of preparing same
EP1545798A4 (en) 2002-08-02 2006-06-14 Us Gov Health & Human Serv NETWORKED NITROGEN OXIDE RELEASING POLYAMINE-COATED SUBSTRATES, THESE COMPOSITIONS AND MANUFACTURING PROCESSES DAF R
WO2005067986A1 (en) 2004-01-07 2005-07-28 Noxilizer, Inc. Sterilization system and device
US8017074B2 (en) * 2004-01-07 2011-09-13 Noxilizer, Inc. Sterilization system and device
US7569559B2 (en) * 2004-02-09 2009-08-04 Noxilizer, Inc. Nitric oxide-releasing molecules
US20070232996A1 (en) * 2004-04-29 2007-10-04 Cube Medical A/S Balloon for Use in Angioplasty with an Outer Layer of Nanofibers
US8134010B2 (en) * 2004-05-05 2012-03-13 Renopharm Ltd. Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof
US7968575B2 (en) * 2004-05-05 2011-06-28 Renopharm Ltd. Nitric oxide donors and uses thereof
GB0419416D0 (en) * 2004-09-01 2004-10-06 Inst Of Ex Botany Ascr 4-Arylazo-3,5-Diamino-Pyrazole compounds and use thereof
DE102004043279A1 (de) * 2004-09-08 2006-03-23 Theo Woike Verfahren und Vorrichtung zum biologischen, medizinischen und pharmazeutischen Gebrauch des Nitrosylmoleküls NO durch optische Anregung von metastabilen Zuständen in Nitrosylkomplexen
EP1888510A4 (en) 2005-05-27 2013-01-16 Univ North Carolina NITROGEN OXIDE-RELATED PARTICLES FOR NITROGEN OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS
US7968533B2 (en) * 2006-03-07 2011-06-28 Duke University Ethyl nitrite as a gastrointestinal smooth muscle relaxant and diagnostic and therapeutic uses thereof
US9259535B2 (en) 2006-06-22 2016-02-16 Excelsior Medical Corporation Antiseptic cap equipped syringe
US11229746B2 (en) 2006-06-22 2022-01-25 Excelsior Medical Corporation Antiseptic cap
US7875671B2 (en) 2006-08-03 2011-01-25 Bridgestone Corporation Process for preparing filler-dispersed polymeric compositions
US8063165B2 (en) 2007-06-18 2011-11-22 Bridgestone Corporation Functional polymers prepared with sulfur-containing initiators
PL2197417T3 (pl) 2007-10-17 2012-08-31 Pharmagenix Ag Kompozycja farmaceutyczna zawierająca S-nitrozoglutation i polisacharyd
US7910574B2 (en) * 2007-12-11 2011-03-22 Illinois State University Treatments for the control of schistosomiasis
US20090170933A1 (en) * 2007-12-26 2009-07-02 Cook Incorporated Method for removing a medical device from a spasmodic constriction in a bodily passageway
US20110104308A1 (en) * 2008-05-09 2011-05-05 Duke University Treatment For Diseases Relying On Discovery That Thioredoxin Mediates Nitric Oxide
WO2010044875A2 (en) * 2008-10-16 2010-04-22 Novan, Inc. Nitric oxide releasing particles for oral care applications
US9078992B2 (en) 2008-10-27 2015-07-14 Pursuit Vascular, Inc. Medical device for applying antimicrobial to proximal end of catheter
EP2517736B1 (en) 2009-02-23 2014-03-26 Noxilizer, Inc. Device for gas sterilization
US9309347B2 (en) 2009-05-20 2016-04-12 Biomedical, Inc. Bioresorbable thermoset polyester/urethane elastomers
US8992601B2 (en) 2009-05-20 2015-03-31 480 Biomedical, Inc. Medical implants
US9265633B2 (en) 2009-05-20 2016-02-23 480 Biomedical, Inc. Drug-eluting medical implants
WO2010135433A1 (en) * 2009-05-20 2010-11-25 Arsenal Medical, Inc. Medical implant
US8888840B2 (en) * 2009-05-20 2014-11-18 Boston Scientific Scimed, Inc. Drug eluting medical implant
US20110319987A1 (en) 2009-05-20 2011-12-29 Arsenal Medical Medical implant
WO2011022652A1 (en) 2009-08-21 2011-02-24 Novan, Inc. Topical gels
BR112012003804B1 (pt) 2009-08-21 2019-02-19 Novan, Inc. Curativo para ferimentos, método para formar um curativo para ferimentos, e, kit de curativo para ferimento
US8372133B2 (en) 2009-10-05 2013-02-12 480 Biomedical, Inc. Polymeric implant delivery system
WO2011047013A1 (en) * 2009-10-13 2011-04-21 Novan, Inc. Nitric oxide-releasing coatings
BR112012015120B1 (pt) 2009-12-22 2020-07-21 Bridgestone Corporation composição de modificador de vinila melhorada e processos para a utilização da mesma
WO2011082098A1 (en) 2009-12-30 2011-07-07 The Rockefeller University Lysine and arginine methyltransferase inhibitors for treating cancer
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
CN107236061B (zh) 2010-12-30 2020-08-07 株式会社普利司通 氨基硅烷引发剂及由其制备的官能化聚合物
ES2695173T3 (es) 2011-02-28 2019-01-02 Novan Inc Partículas de sílice modificadas con S-nitrosotiol que liberan óxido nítrico y procedimientos de fabricación de las mismas
US10166381B2 (en) 2011-05-23 2019-01-01 Excelsior Medical Corporation Antiseptic cap
CA2841832C (en) 2011-07-12 2019-06-04 Icu Medical, Inc. Device for delivery of antimicrobial agent into a trans-dermal catheter
TWI585115B (zh) 2011-12-15 2017-06-01 普利司通股份有限公司 經穩定之多價陰離子聚合反應引發劑及其製備方法
JP6334514B2 (ja) 2012-05-01 2018-05-30 株式会社ブリヂストン オルガノホスフィン官能基を有するポリジエンおよびジエンコポリマー
PL3080167T3 (pl) 2013-12-12 2025-03-03 Firestone Polymers, Llc Sposób wytwarzania kompozycji polimerowych zawierających funkcjonalizowane polimery
JP6546988B2 (ja) 2014-05-02 2019-07-17 エクセルシオール・メディカル・コーポレイションＥｘｃｅｌｓｉｏｒ Ｍｅｄｉｃａｌ Ｃｏｒｐｏｒａｔｉｏｎ 防腐キャップのためのストリップパッケージ
DK3294404T3 (da) 2015-05-08 2025-09-08 Icu Medical Inc Medicinske konnektorer konfigureret til at modtage emittere af terapeutiske midler
US10519266B2 (en) 2015-09-23 2019-12-31 Bridgestone Corporation Polydienes and diene copolymers using 1,1-bis(hydrocarbylthio)hydrocarbyl-1-ene compounds
EP3523367A4 (en) * 2016-10-07 2020-06-03 The University Of North Carolina At Chapel Hill S-NITROSOTHIOL-MEDIATED HYPERBRANCHED POLYESTER
PL3525865T3 (pl) 2016-10-14 2023-02-06 Icu Medical, Inc. Nasadki dezynfekcyjne dla łączników medycznych
US11072668B2 (en) 2017-01-03 2021-07-27 The University Of North Carolina At Chapel Hill Nitric oxide-releasing alginates as biodegradable antibacterial scaffolds and methods pertaining thereto
JP7403152B2 (ja) 2017-03-28 2023-12-22 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル 生分解可能な抗菌性スキャフォールドとしての一酸化窒素放出性ポリアミノグリコシドおよびそれに関する方法背景
WO2018204206A2 (en) 2017-05-01 2018-11-08 Icu Medical, Inc. Medical fluid connectors and methods for providing additives in medical fluid lines
AU2018369760B2 (en) 2017-11-15 2025-01-02 The University Of North Carolina At Chapel Hill Nitric oxide-releasing hyperbranched compounds as antibacterial scaffolds and methods pertaining thereto
WO2019173539A1 (en) 2018-03-06 2019-09-12 The University Of North Carolina At Chapel Hill Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds and methods pertaining thereto
US11517732B2 (en) 2018-11-07 2022-12-06 Icu Medical, Inc. Syringe with antimicrobial properties
US11541221B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Tubing set with antimicrobial properties
US11400195B2 (en) 2018-11-07 2022-08-02 Icu Medical, Inc. Peritoneal dialysis transfer set with antimicrobial properties
US11541220B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Needleless connector with antimicrobial properties
US11534595B2 (en) 2018-11-07 2022-12-27 Icu Medical, Inc. Device for delivering an antimicrobial composition into an infusion device
JP2022513096A (ja) 2018-11-21 2022-02-07 アイシーユー・メディカル・インコーポレーテッド リング及びインサートを有するキャップを備える抗菌装置
JP7645546B2 (ja) 2018-12-28 2025-03-14 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル 一酸化窒素放出抗菌性ポリマーおよびそれから製造された足場、ならびにそれに関する方法
CA3204371A1 (en) 2020-12-07 2022-06-16 Icu Medical, Inc. Peritoneal dialysis caps, systems and methods

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5025001A (en) 1988-06-15 1991-06-18 Brigham And Women's Hospital S-nitroso derivatives of ACE inhibitors and the use thereof
EP0412699B1 (en) 1989-08-07 1994-04-27 Takeda Chemical Industries, Ltd. Nitrosothiol derivatives, their production and use
US5380758A (en) 1991-03-29 1995-01-10 Brigham And Women's Hospital S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
IL101406A (en) 1991-03-29 1998-02-08 Brigham & Womens Hospital Pharmaceutical compositions containing s-nitrosothiol derivatives
US5385937A (en) 1991-04-10 1995-01-31 Brigham & Women's Hospital Nitrosation of homocysteine as a method for treating homocysteinemia
US5650447A (en) 1992-08-24 1997-07-22 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Nitric oxide-releasing polymers to treat restenosis and related disorders
EP1393723A3 (en) 1993-09-17 2004-10-20 The Brigham And Women's Hospital, Inc. Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces
US5583101A (en) 1994-07-15 1996-12-10 Harvard College Use of nitrogen oxide species and adducts to inhibit skeletal muscle contraction
WO1996003139A1 (en) 1994-07-27 1996-02-08 Duke University Use of nitric oxide or nitric oxide adducts to preserve platelets
US5612314A (en) 1995-04-21 1997-03-18 Brigham & Women's Hospital Nitrosylated neuropeptides
US5770645A (en) 1996-08-02 1998-06-23 Duke University Medical Center Polymers for delivering nitric oxide in vivo
US6207855B1 (en) 1998-06-23 2001-03-27 Duke University Medical Center Stable no-delivering compounds

Also Published As

Publication number Publication date
US20030096862A1 (en) 2003-05-22
US20060217439A1 (en) 2006-09-28
US6359167B2 (en) 2002-03-19
US20010000039A1 (en) 2001-03-15
US6207855B1 (en) 2001-03-27
WO1999067210A1 (en) 1999-12-29
DE69942338D1 (de) 2010-06-17
US20040019105A1 (en) 2004-01-29
US6488951B2 (en) 2002-12-03
EP1089969B1 (en) 2010-05-05
US7015347B2 (en) 2006-03-21
US7745656B2 (en) 2010-06-29
US20020099330A1 (en) 2002-07-25
US6583311B2 (en) 2003-06-24
JP2002518473A (ja) 2002-06-25
CA2335989A1 (en) 1999-12-29
EP1089969A1 (en) 2001-04-11

Similar Documents

Publication Publication Date Title
AU4580599A (en) Stable no-delivering compounds
AU2863899A (en) New compounds
AUPP796798A0 (en) New compound
AU4260199A (en) Novel compounds
AU1424200A (en) Compounds
AU4501699A (en) Aminoazole compounds
AU5980899A (en) Novel compounds
AU2014800A (en) Novel compounds
AU1434500A (en) Compounds
AU4814699A (en) Novel compounds
AUPP549998A0 (en) New compound
AU5516599A (en) Substituted 3-aryl-pyrazoles
AU2187799A (en) Novel taxaneterpine compounds
AU4507899A (en) Substituted n-aryl-o-alkyl-carbamates
AU3204999A (en) Futureball
AU2609599A (en) Sensor-coupling
AU4511499A (en) Substituted cyclooctadepsipeptides
AU2069199A (en) Codelets
AU2725599A (en) Substituted alxoxycarbonyl compounds
AU2863799A (en) New compounds
AU1055399A (en) Rollerboard
AU5661399A (en) Compounds
AU1192300A (en) Novel compounds
AU2840799A (en) 1-phosphanorbornadienes
AU3715899A (en) Di-peroxy compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase